Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06810375 · ClinicalTrials.gov registry record · Phase 3
Erector Spinae Versus Intercostal Nerve Blocks With Liposomal Bupivacaine for Analgesia in Thoracic Surgery
A Phase 3 study of Lung Cancers, sponsored by George Washington University.
- Recruiting
- Registry status
- Phase 3
- Development phase
- 120
- Enrollment target
- 1
- Study location
NCT06810375: Recruiting Phase 3 study of Lung Cancers, sponsored by George Washington University.
NCT06810375 is a Phase 3 study of Lung Cancers that is actively recruiting participants, run by George Washington University. The registered enrollment target is 120 participants, below the 158-participant average among 5 other Lung Cancers trials with a reported enrollment target (24% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06810375, a Phase 3 study of Lung Cancers, is actively recruiting participants, sponsored by George Washington University.
- RECRUITING
- Registry status
- Phase 3
- Development phase
- 120 participants
- Enrollment target
- 1
- Study location
Study Summary
This clinical trial compares efficacy in postoperative pain management in thoracic surgery between erector spinae block versus liposomal bupivacaine injections.
Primary Outcome
Study team will assess postoperative pain scores at 6, 12, 24 and 48 hours (Minimum numerical pain score of 0 and a maximum of 10)
Conditions Studied
Interventions
- DRUG Erector Spinae (ESP) Block with Bupivacaine (Marcaine®)
- DRUG Intercostal nerve block
Study Locations (1)
District of Columbia
- The George Washington University Hospital - Washington D.C.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 120 participants |
| Start Date | 2025-03-01 |
| Est. Completion | 2029-02-28 |
| Phase | Phase 3 |
What NCT06810375 shows while recruiting
NCT06810375 is an interventional study that assigns participants to a tested intervention. The registered 120 participants enrollment target is mid-sized for trials with a published cap, below the 158-participant average among 5 other Lung Cancers trials with a reported enrollment target (24% lower).
The record links to 1 condition, with Lung Cancers appearing as the primary indexed condition, and to 2 interventions - of which Erector Spinae (ESP) Block with Bupivacaine (Marcaine®) is the first listed.
NCT06810375 reports a single indexed study location in District of Columbia.
Frequently Asked Questions
What is clinical trial NCT06810375 about?
NCT06810375 is a clinical study titled "Erector Spinae Versus Intercostal Nerve Blocks With Liposomal Bupivacaine for Analgesia in Thoracic Surgery". This clinical trial compares efficacy in postoperative pain management in thoracic surgery between erector spinae block versus liposomal bupivacaine injections.
What is the current status of trial NCT06810375?
This trial is currently recruiting. It is a Phase 3 study. The enrollment target is 120 participants. The study started on 2025-03-01. Estimated completion is 2029-02-28.
What conditions does trial NCT06810375 study?
This clinical trial studies the following conditions: Lung Cancers.
What interventions are being tested in trial NCT06810375?
The interventions under investigation include: Erector Spinae (ESP) Block with Bupivacaine (Marcaine®) (DRUG), Intercostal nerve block (DRUG).
Who is sponsoring clinical trial NCT06810375?
This trial is sponsored by George Washington University, which has 133 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06810375 being conducted?
This trial has 1 study location across District of Columbia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Lung Cancers
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Rapid Autopsy and Procurement of Cancer Tissue
RECRUITING
-
Bright Light Therapy on Sleep Health in Lung Cancer Patients
RECRUITING · NA
-
AVENTINE-1: Study of AVZO-1418 as a Single Agent and in Combination Therapy in Patients With Locally Advanced or Metastatic Solid Tumors (AVZO-1418-1001)
RECRUITING · Phase 1
-
A Single Dose, Open-Label, Dose-escalation Study of the Safety and Imaging Characteristics of LS301-IT for Intraoperative Imaging of Lung Cancer
ACTIVE NOT RECRUITING · Phase 1
-
Evaluating a Bidirectional Priming Intervention for Goals-of-care Communication in Oncology
COMPLETED · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01174108 · 120 participants · Phase 2
Allogeneic Hematopoietic Stem Cell Transplantation for Severe Aplastic Anemia and Other Bone Marrow Failure Syndromes Using G-CSF Mobilized CD34+ Selected Hematopoietic Precursor Cells Co-Infused With a Reduced Dose of Non-Mobilized Donor T-cells
- NCT01627301 · 120 participants · NA
Sympathetic Overactivity in Post-traumatic Stress Disorder
- NCT02025023 · 120 participants · Phase 3
Local 5-Fluorouracil Injection for the Treatment of Chalazia: A Prospective, Comparative Study
- NCT02128906 · 120 participants · Phase 2
Radiotherapy With Cisplatin vs. Docetaxel-cetuximab in HNSCC: ERCC1 Biomarker Enrichment and Interaction Design
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI